Cross-reactivity of a vancomycin degradation product in three immunoassays of vancomycin
Hortin, G.L.; Landt, M.; Wilhite, T.; Smith, C.H.
Clinical Chemistry 37(11): 2009
1991
ISSN/ISBN: 0009-9147 PMID: 1934480 Document Number: 367860
Document emailed within 1 workday
Related Documents
Sauer, P.; Síla, J.; Vágnerová, I. 2009: Virulence factors in vancomycin-susceptible and vancomycin-resistant enterococci in the University Hospital Olomouc Klinicka Mikrobiologie a Infekcni Lekarstvi 15(2): 44-47Walczyk, M.H.; Hill, D.; Arai, A.; Wolfson, M. 1988: Acute renal failure owing to inadvertent vancomycin overdose. Vancomycin removal by continuous arteriovenous hemofiltration Annals of Clinical and Laboratory Science 18(6): 440-443
Brouard, S.; Lelan, J.; Lancien, G.; Bonnaure, M.; Cormier, M.; Langlais, F. 1997: Tricalcium phosphate, vector of antibiotics: gentamycin and vancomycin. in vitro physicochemical characterization, study of biomaterial porosity and gentamycin and vancomycin elution Chirurgie; Memoires de l'Academie de Chirurgie 122(7): 397-403
Matzke, G.R.; Kovarik, J.M.; Rybak, M.J.; Boike, S.C. 1985: Evaluation of the vancomycin-clearance:creatinine-clearance relationship for predicting vancomycin dosage Clinical Pharmacy 4(3): 311-315
Smyth, E.G.; Pallett, A.P. 1988: Vancomycin British Journal of Hospital Medicine 39(4): 308-312
Geraci, J.E. 1977: Vancomycin Mayo Clinic Proceedings 52(10): 631-634
Furuta, I.; Kitahashi, T. 1995: Vancomycin Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Su Pt 1: 1028-1030
Garrelts, J.C.; Peterie, J.D. 1985: Vancomycin and the "red man's syndrome" New England Journal of Medicine 312(4): 245
Uttley, A.H.; Woodford, N.; Johnson, A.P.; Cookson, B.; George, R.C. 1993: Vancomycin-resistant enterococci Lancet 342(8871): 615; Author Reply 616
Lissac, J.; Avril, J.L. 1977: Synergistins, vancomycin and polymyxins La Revue du Praticien 27(45): 2959-2964
Brummett, R.E. 1993: Ototoxicity of vancomycin and analogues Otolaryngologic Clinics of North America 26(5): 821-828
Garrelts, J.C.; Smith, D.F.; Ast, D.; LaRocca, J.; Peterie, J.D. 1988: Phlebitis associated with vancomycin therapy Clinical Pharmacy 7(10): 720-721
Marovac, J.; Campos, M.I. 2000: Vancomycin resistant Enterococcus faecium Revista Medica de Chile 128(6): 685-686
Zaĭtsev, A.A.; Karpov, O.I.; Sidorenko, S.V. 2003: Staphylococci and vancomycin--confrontation trends Antibiotiki i Khimioterapiia 48(6): 20-26
Rattanaumpawan, P.; Thamlikitkul, V.; Chokepaibulkit, K.; Lohsiriwat, D.; Aswapokee, N. 2006: Vancomycin overuse in Siriraj Hospital Journal of the Medical Association of Thailand 89(Suppl 5): S125-S132
Macías, E.; Moreno, E.; Dávila, I.; Laffond, E.; Ruíz, A.; Batista, J.C.; Lorente, F. 2008: Reaction to teicoplanin with tolerance to vancomycin Journal of Investigational Allergology and Clinical Immunology 18(1): 71-72
Fraser, G.L.; D'Amato, S. 1993: Vancomycin pharmacokinetics in elderly patients Clinical Pharmacy 12(7): 481
Gobernado, M. 2002: Staphylococcus aureus resistance. now vancomycin Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 15(3): 211-214
Kobayashi, K.; Rao, M.; Smith, J.M.; Cook, G.M. 1999: Vancomycin resistant enterococci in New Zealand New Zealand Medical Journal 112(1084): 105
Duró, J.C.; Faus, S.; Blanch, J.; Benito, P. 1987: Red neck syndrome induced by vancomycin Medicina Clinica 89(5): 218